CN116648455A - 制备脂质肽的方法 - Google Patents

制备脂质肽的方法 Download PDF

Info

Publication number
CN116648455A
CN116648455A CN202180086887.9A CN202180086887A CN116648455A CN 116648455 A CN116648455 A CN 116648455A CN 202180086887 A CN202180086887 A CN 202180086887A CN 116648455 A CN116648455 A CN 116648455A
Authority
CN
China
Prior art keywords
formula
group
carbon atoms
compound represented
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180086887.9A
Other languages
English (en)
Chinese (zh)
Inventor
庄子武明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Publication of CN116648455A publication Critical patent/CN116648455A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202180086887.9A 2020-12-25 2021-12-24 制备脂质肽的方法 Pending CN116648455A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020217730 2020-12-25
JP2020-217730 2020-12-25
PCT/JP2021/048365 WO2022138953A1 (ja) 2020-12-25 2021-12-24 脂質ペプチドの製造方法

Publications (1)

Publication Number Publication Date
CN116648455A true CN116648455A (zh) 2023-08-25

Family

ID=82158264

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180086887.9A Pending CN116648455A (zh) 2020-12-25 2021-12-24 制备脂质肽的方法

Country Status (7)

Country Link
US (1) US20240067675A1 (https=)
EP (1) EP4265629A4 (https=)
JP (1) JP7787501B2 (https=)
KR (1) KR20230124616A (https=)
CN (1) CN116648455A (https=)
TW (1) TW202241920A (https=)
WO (1) WO2022138953A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202241919A (zh) * 2020-12-25 2022-11-01 日商日產化學股份有限公司 脂質胜肽之製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1184770C2 (de) * 1961-06-01 1965-09-02 Hoffmann La Roche Verfahren zur Herstellung von antibacteriell wirksamen Peptiden
JP5183907B2 (ja) 2006-11-07 2013-04-17 株式会社パーマケム・アジア ペリンドプリルの前駆体の製造方法、及び、ペリンドプリルエルブミンの製造方法と精製方法
JP5500071B2 (ja) 2008-08-01 2014-05-21 日産化学工業株式会社 新規脂質ジペプチド並びにゲル
CN102596986B (zh) 2009-09-07 2015-08-05 日产化学工业株式会社 脂质肽化合物的制造方法

Also Published As

Publication number Publication date
TW202241920A (zh) 2022-11-01
KR20230124616A (ko) 2023-08-25
JP7787501B2 (ja) 2025-12-17
EP4265629A1 (en) 2023-10-25
JPWO2022138953A1 (https=) 2022-06-30
US20240067675A1 (en) 2024-02-29
EP4265629A4 (en) 2024-11-27
WO2022138953A1 (ja) 2022-06-30

Similar Documents

Publication Publication Date Title
AU2018244916B2 (en) Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
CN104540807B (zh) 用于制备吡唑甲酸衍生物的方法
CA2750353C (en) Method for manufacturing a boronic acid ester compound
TW202045467A (zh) 肽化合物的製造方法、保護基形成用試藥及縮合多環芳香族烴化合物
US9115052B2 (en) Separation of an enantiomer mixture of (R)- and (S)-3-amino-1-butanol
WO2019238103A1 (zh) 吡啶胺基嘧啶衍生物的制备方法及其中间体
WO2019049824A1 (ja) 保護ｌ－カルノシン誘導体、ｌ－カルノシン、および結晶性ｌ－カルノシン亜鉛錯体の製造方法
CN116648455A (zh) 制备脂质肽的方法
KR101754793B1 (ko) 지질 펩티드 화합물의 제조방법
TWI729662B (zh) 一種磺胺類化合物及製備磺胺類化合物的製程
WO2011156355A1 (en) Production method of phenyl guanidine salts and their intermediates
CN116113636A (zh) 4-硼-l-苯基丙氨酸及其中间体的制造方法
CN116615435A (zh) 制备脂质肽的方法
CN109956865B (zh) 一种西格列汀中间体的制备方法
CN105189519B (zh) 用于制备硼酸中间体的方法
CN109988070B (zh) 反式-1-羟基-1-(三氟甲基)-3-氨基环丁烷盐酸盐的中间体及制备方法和应用
US9175019B2 (en) Industrial process for the preparation of N-alkyl-N-trialkylsilylamides
WO2025160705A1 (zh) 一种lfa-1抑制剂的制备方法
WO2025063265A1 (ja) ペプチド化合物の製造方法、保護基形成用試薬、およびジナフチルメチル化合物
CN103209961A (zh) 用于制备2,3-二氨基丙酸衍生物的对映异构体形式的方法
TW201943707A (zh) 經取代的二氫茚-4-甲醯胺化合物的製備方法
CN106366010A (zh) 一种金刚烷甘氨酸衍生物及其盐的合成方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination